Agios Pharmaceuticals (AGIO) Assets Growth (1y) (2013 - 2026)

Agios Pharmaceuticals (AGIO) Assets Growth (1y) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Agios Pharmaceuticals 2.13 Bn 2.13 Bn 19.43 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -23.82%
Dec 31, 2025 -22.00%
Sep 30, 2025 -22.66%
Jun 30, 2025 90.31%
Mar 31, 2025 83.06%
Dec 31, 2024 77.48%
Sep 30, 2024 77.89%
Jun 30, 2024 -28.76%
Mar 31, 2024 -26.20%
Dec 31, 2023 -24.35%
Sep 30, 2023 -14.66%
Jun 30, 2023 -13.36%
Mar 31, 2023 -13.82%
Dec 31, 2022 -13.84%
Sep 30, 2022 -23.43%
Jun 30, 2022 -33.19%
Mar 31, 2022 -46.32%
Dec 31, 2021 68.56%
Sep 30, 2021 69.68%
Jun 30, 2021 92.04%